Surface properties and ion release from fluoride-containing bioactive glasses promote osteoblast differentiation and mineralization in vitro

Acta Biomaterialia

Volumn 9, Issue 3, 2013, Pages 5771-5779

  Gentleman, E ^a,b   Stevens, M M ^a   Hill, R G ^c   Brauer, D S ^c,d  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Bioactive glass; Bone regeneration; Fluoride; Osteoblast

Indexed keywords

BIOACTIVE GLASS; CELL PROLIFERATION; IONS; MINERALOGY; OSTEOBLASTS; PHOSPHATASES; SILICATES;

BONE FORMATION; BONE REGENERATION; DENTAL CARIES; FLUORIDE; IN-VITRO; ION RELEASE; OSTEOBLAST DIFFERENTIATION; OSTEOBLAST MINERALIZATION; PROPERTY; SILICATE STRUCTURES;

BONE;

ALKALINE PHOSPHATASE; BIOACTIVE GLASS; FLUORIDE; FLUORIDE SODIUM; GLASS; INTERLEUKIN 6; UNCLASSIFIED DRUG;

ARTICLE; BONE MINERALIZATION; CELL CULTURE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME METABOLISM; HUMAN; HUMAN CELL; IN VITRO STUDY; ION TRANSPORT; OSTEOBLAST; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 84873171870     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2012.10.043     Document Type: Article

References (49)

1. M.R. Norton, and J. Wilson Dental implants placed in extraction sites implanted with bioactive glass: human histology and clinical outcome Int J Oral Maxillofac Implants 17 2 2002 Mar-Apr 249 257
2. K.R. Rust, G.T. Singleton, J. Wilson, and P.J. Antonelli Bioglass middle ear prosthesis: long-term results Am J Otol 17 3 1996 May 371 374 (Pubitemid 26266570)
3. E. Gentleman, Y.C. Fredholm, G. Jell, N. Lotfibakhshaiesh, M.D. O'Donnell, and R.G. Hill The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro Biomaterials 31 14 2010 May 3949 3956
4. J.D. Featherstone The science and practice of caries prevention J Am Dent Assoc 131 7 2000 Jul 887 899
5. M.W. Lundy, J.E. Wergedal, E. Teubner, J. Burnell, D. Sherrard, and D.J. Baylink The effect of prolonged fluoride therapy for osteoporosis: bone composition and histology Bone 10 5 1989 321 327 (Pubitemid 20072024)
6. B.L. Riggs, S.F. Hodgson, W.M. O'Fallon, E.Y. Chao, H.W. Wahner, and J.M. Muhs Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis N Engl J Med 322 12 1990 Mar 22 802 809 (Pubitemid 20094143)
7. P.J. Meunier, J.L. Sebert, J.Y. Reginster, D. Briancon, T. Appelboom, and P. Netter Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVO Study Osteoporos Int 8 1 1998 4 12 (Pubitemid 28085478)
8. E.D. Eanes, and A.H. Reddi Effect of fluoride on bone-mineral apatite Metab Bone Dis Relat 2 1 1979 3 10
9. R. Balena, M. Kleerekoper, J.A. Foldes, M.S. Shih, D.S. Rao, and H.C. Schober Effects of different regimens of sodium fluoride treatment for osteoporosis on the structure, remodeling and mineralization of bone Osteoporos Int 8 5 1998 428 435 (Pubitemid 28486710)
10. S.L. Choubisa Endemic fluorosis in southern Rajasthan, India Fluoride 34 1 2001 Feb 61 70 (Pubitemid 32525275)
11. R.G.G. Russell Bisphosphonates: mode of action and pharmacology Pediatrics 119 2007 Mar S150 S162 (Pubitemid 46397937)
12. B.G.M. Durie, M. Katz, and J. Crowley Osteonecrosis of the jaw and bisphosphonates N Engl J Med 353 1 2005 Jul 7 99 100
13. A.S. Neviaser, J.M. Lane, B.A. Lenart, F. Edobor-Osula, and D.G. Lorich Low-energy femoral shaft fractures associated with alendronate use J Orthopaedic Trauma 22 5 2008 May-Jun 346 350 (Pubitemid 351630250)
14. R.L. Jilka Molecular and cellular mechanisms of the anabolic effect of intermittent PTH Bone 40 6 2007 Jun 1434 1446 (Pubitemid 46756429)
15. I.R. Reid, T. Cundy, A.B. Grey, A. Horne, J. Clearwater, and R. Ames Addition of monofluorophosphate to estrogen therapy in postmenopausal osteoporosis: a randomized controlled trial J Clin Endocrinol Metab 92 7 2007 Jul 2446 2452 (Pubitemid 47037341)
16. C.G. Bellows, J.N. Heersche, and J.E. Aubin The effects of fluoride on osteoblast progenitors in vitro J Bone Miner Res 5 Suppl. 1 1990 Mar S101 S105 (Pubitemid 20284894)
17. P. Vestergaard, N.R. Jorgensen, P. Schwarz, and L. Mosekilde Effects of treatment with fluoride on bone mineral density and fracture risk-a meta-analysis Osteoporos Int 19 3 2008 Mar 257 268
18. J.E. Wergedal, K.H. Lau, and D.J. Baylink Fluoride and bovine bone extract influence cell proliferation and phosphatase activities in human bone cell cultures Clin Orthop Relat Res 233 1988 Aug 274 282
19. J.R. Farley, J.E. Wergedal, and D.J. Baylink Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone-forming cells Science 222 4621 1983 Oct 21 330 332 (Pubitemid 13013396)
20. 3H] thymidine incorporation and alkaline phosphatase production by human osteoblasts Metabolism 39 11 1990 Nov 1118 1121 (Pubitemid 20376339)
21. J.P. Rodriguez, and G. Rosselot Sodium fluoride induces changes on proteoglycans synthesized by avian osteoblasts in culture J Cell Biochem 83 4 2001 607 616 (Pubitemid 33055437)
22. M. Kassem, L. Mosekilde, and E.F. Eriksen Effects of fluoride on human bone cells in vitro: differences in responsiveness between stromal osteoblast precursors and mature osteoblasts Eur J Endocrinol 130 4 1994 Apr 381 386 (Pubitemid 24135726)
23. M. Kassem, L. Mosekilde, and E.F. Eriksen 1,25-Dihydroxyvitamin D3 potentiates fluoride-stimulated collagen type I production in cultures of human bone marrow stromal osteoblast-like cells J Bone Miner Res 8 12 1993 Dec 1453 1458 (Pubitemid 23342682)
24. P. Chavassieux, G. Boivin, C.M. Serre, and P.J. Meunier Fluoride increases rat osteoblast function and population after in vivo administration but not after in vitro exposure Bone 14 5 1993 Sep-Oct 721 725 (Pubitemid 23294025)
25. R.G. Hill, and D.S. Brauer Predicting the bioactivity of glasses using the network connectivity or split network models J Non-Cryst Solids 357 24 2011 Dec 3884 3887
26. D.S. Brauer, N. Karpukhina, R.V. Law, and R.G. Hill Structure of fluoride-containing bioactive glasses J Mater Chem 19 31 2009 5629 5636
27. D.S. Brauer, A. Al-Noaman, R.G. Hill, and H. Doweidar Density-structure correlations in fluoride-containing bioactive glasses Mater Chem Phys 130 1-2 2011 Oct 17 121 125
28. E.A. Effah Kaufmann, P. Ducheyne, and I.M. Shapiro Evaluation of osteoblast response to porous bioactive glass (45S5) substrates by RT-PCR analysis Tissue Eng 6 1 2000 Feb 19 28 (Pubitemid 30123979)
29. E. Gentleman, E.A. Nauman, K.C. Dee, and G.A. Livesay Short collagen fibers provide control of contraction and permeability in fibroblast-seeded collagen gels Tissue Eng 10 3-4 2004 Mar-Apr 421 427 (Pubitemid 38580263)
30. E. Gentleman, E.A. Nauman, G.A. Livesay, and K.C. Dee Collagen composite biomaterials resist contraction while allowing development of adipocytic soft tissue in vitro Tissue Eng 12 6 2006 Jun 1639 1649 (Pubitemid 44174797)
31. M. Allen, P. Millett, E. Dawes, and N. Rushton Lactate dehydrogenase activity as a rapid and sensitive test for the quantification of cell numbers in vitro Clin Mater 16 4 1994 189 194
32. E.M. Carlisle Silicon: a requirement in bone formation independent of vitamin D1 Calcif Tissue Int 33 1 1981 27 34 (Pubitemid 11172209)
33. D.S. Brauer, E. Gentleman, D.F. Farrar, M.M. Stevens, and R.G. Hill Benefits and drawbacks of zinc in glass ionomer bone cements Biomed Mater 6 4 2011 Aug 045007
34. D.S. Brauer, N. Karpukhina, M.D. O'Donnell, R.V. Law, and R.G. Hill Fluoride-containing bioactive glasses: effect of glass design and structure on degradation, pH and apatite formation in simulated body fluid Acta Biomater 6 8 2010 Aug 3275 3282
35. M. Mneimne, R.G. Hill, A.J. Bushby, and D.S. Brauer High phosphate content significantly increases apatite formation of fluoride-containing bioactive glasses Acta Biomater 7 4 2011 Apr 1827 1834
36. D.S. Brauer, M. Mneimne, and R.G. Hill Fluoride-containing bioactive glasses: fluoride loss during melting and ion release in tris buffer solution J Non-Cryst Solids 357 18 2011 Sep 15 3328 3333
37. L.L. Hench The story of Bioglass (R) J Mater Sci Mater M 17 11 2006 Nov 967 978
38. C.G. Bellows, J.E. Aubin, J.N. Heersche, and M.E. Antosz Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations Calcif Tissue Int 38 3 1986 Mar 143 154 (Pubitemid 16160917)
39. M.M. Dvorak, A. Siddiqua, D.T. Ward, D.H. Carter, S.L. Dallas, and E.F. Nemeth Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones Proc Natl Acad Sci USA 101 14 2004 Apr 6 5140 5145 (Pubitemid 38469215)
40. L. Bergandi, V. Aina, S. Garetto, G. Malavasi, E. Aldieri, and E. Laurenti Fluoride-containing bioactive glasses inhibit pentose phosphate oxidative pathway and glucose 6-phosphate dehydrogenase activity in human osteoblasts Chem Biol Interact 183 3 2010 Feb 12 405 415
41. J.R. Carlson, and J.W. Suttie Effects of sodium fluoride on HeLa cells. I. Growth sensitivity and adaption Exp Cell Res 45 2 1967 415
42. D. Slamenova, A. Gabelova, and K. Ruppova Cytotoxicity and genotoxicity testing of sodium fluoride on Chinese hamster V79 cells and human EUE cells Mutat Res 279 2 1992 May 16 109 115
43. A. Yang, D.L. Cardona, and F.A. Barile In vitro cytotoxicity testing with fluorescence-based assays in cultured human lung and dermal cells Cell Biol Toxicol 18 2 2002 97 108 (Pubitemid 34467942)
44. Y. Ishimi, C. Miyaura, C.H. Jin, T. Akatsu, E. Abe, and Y. Nakamura IL-6 is produced by osteoblasts and induces bone resorption J Immunol 145 10 1990 Nov 15 3297 3303
45. C. Scheidt-Nave, H. Bismar, G. Leidig-Bruckner, H. Woitge, M.J. Seibel, and R. Ziegler Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause J Clin Endocrinol Metab 86 5 2001 May 2032 2042 (Pubitemid 32472916)
46. E.C. Buxton, W. Yao, and N.E. Lane Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34) J Clin Endocrinol Metab 89 7 2004 Jul 3332 3336 (Pubitemid 38951900)
47. X. Yang, B.F. Ricciardi, A. Hernandez-Soria, and Y. Shi Pleshko Camacho N, Bostrom MP. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice Bone 41 6 2007 Dec 928 936 (Pubitemid 350116738)
48. N.H. Li, Y. Ouchi, Y. Okamoto, A. Masuyama, M. Kaneki, and A. Futami Effect of parathyroid hormone on release of interleukin 1 and interleukin 6 from cultured mouse osteoblastic cells Biochem Biophys Res Commun 179 1 1991 Aug 30 236 242
49. C.W. Lowik, G. van der Pluijm, H. Bloys, K. Hoekman, O.L. Bijvoet, and L.A. Aarden Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis Biochem Biophys Res Commun 162 3 1989 Aug 15 1546 1552 (Pubitemid 19214760)